Skip to content

Basic treatment combined with electroacupuncture Lao Shi Zhen clinical research protocol for the treatment of sepsis and gastrointestinal dysfunction

Basic treatment combined with electroacupuncture Lao Shi Zhen clinical research protocol for the treatment of sepsis and gastrointestinal dysfunction

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000428
Enrollment
Unknown
Registered
2024-09-12
Start date
2024-08-09
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Experimental Group:Lao Shi zhen acupuncture points (Shangwan ZhongwanXiawan Qihai Tianshu Neiguan Zusanli)
In addition to the basic treatment electroacupuncture is given twice a day. 30 minutes of electroacupuncture treatment each time: the needle is inserted into a specific point on the surface of the sk

Sponsors

Beijing Hospital of Traditional Chinese Medicine Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for sepsis (2) Meet the acute gastrointestinal injury classification level I to III (3) Age= 18 years old gender is not limited (4) The patient or family member knows the content of the study agrees to the acupuncture treatment and voluntarily signs the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with primary gastrointestinal diseases such as: gastrointestinal bleeding gastric ulcer gastric cancer (2) Those who are pregnant or preparing to become pregnant or those who cannot take effective measures to prevent pregnancy; (3) Patients with severe mental illness; (4) The expected survival time of patients due to underlying diseases is less than 28 days such as poor control of malignant tumors cardiac arrest within the past 30 days etc.; (5) Confirmed or highly suspected acute infectious diseases such as active viral hepatitis active tuberculosis etc.; (6) Those whose skin is broken or infected at the location of acupuncture points; (7) Participated in clinical intervention trials in the past 3 months; (8) Subjects who are considered by the attending physician to be inappropriate to participate in this trial.

Design outcomes

Primary

MeasureTime frame
28-day mortality;

Secondary

MeasureTime frame
SOFA score;APACHE II. SCORE;Gastrointestinal function indicators (bowel sounds AGI grade);Inflammation-related markers;

Countries

China

Contacts

Public ContactQingquan Liu

Beijing Hospital of Traditional Chinese Medicine Capital Medical University

liuqingquan_2003@126.com13910055687

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026